Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

Heatley, S L; Mullighan, C G; Doherty, K; Danner, S; O'Connor, G M; Hahn, U; Szer, J; Schwarer, A; Bradstock, K; Sullivan, L C; Bardy, P G; Brooks, A G

Heatley, S L; Mullighan, C G; Doherty, K; Danner, S; O'Connor, G M; Hahn, U; Szer, J; Schwarer, A; Bradstock, K; Sullivan, L C; Bardy, P G; Brooks, A G.

Afiliação

Heatley SL; University of Melbourne, Melbourne, Vic, Australia.
Mullighan CG; Australian Red Cross Blood Service, Adelaide, SA, Australia.
Doherty K; St Jude Children's Research Hospital, Memphis, TN, USA.
Danner S; Australian Red Cross Blood Service, Adelaide, SA, Australia.
O'Connor GM; Australian Red Cross Blood Service, Adelaide, SA, Australia.
Hahn U; Royal Adelaide and Queen Elizabeth Hospitals, SA Pathology, Adelaide, SA, Australia.
Szer J; University of Melbourne, Melbourne, Vic, Australia.
Schwarer A; Royal Adelaide and Queen Elizabeth Hospitals, SA Pathology, Adelaide, SA, Australia.
Bradstock K; University of Melbourne, Melbourne, Vic, Australia.
Sullivan LC; Royal Melbourne Hospital, Melbourne, Vic, Australia.
Bardy PG; Alfred Hospital, Melbourne, Vic, Australia.
Brooks AG; Westmead Hospital, Sydney, NSW, Australia.